Latest stories on CMPX
Compass Therapeutics drops as FDA seeks additional trial for lead asset
Seeking Alpha28 · bearishgeneral
Compass Therapeutics says FDA requests new trial for tovecimig
The Fly34 · bearishgeneral
Compass Therapeutics, Inc. (CMPX) files 8-K
SEC 8-K50 · neutralgeneral
Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback
Business Insider38 · neutralgeneral
KuppingerCole Analysts Include Regula in the Leadership Compass for Its Identity Data Control and Document Verification
Business Insider63 · neutralanalyst
Compass Therapeutics price target raised to $7 from $4 at Leerink
The Fly63 · neutralanalyst
Compass Therapeutics GAAP EPS of -$0.13 misses by $0.02
Seeking Alpha34 · bearishearnings
Compass Therapeutics, Inc. (CMPX) files 8-K
SEC 8-K50 · neutralgeneral
Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update
Business Insider56 · neutralearnings
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026 | CMPX Stock News
StockTitan63 · neutralproduct/pr
Compass Therapeutics, Inc. (CMPX) files 8-K
SEC 8-K50 · neutralgeneral
Compass Therapeutics Adopts Second Amended and Restated Bylaws
TipRanks50 · neutralgeneral
Compass Therapeutics, Inc. (CMPX) files 8-K
SEC 8-K50 · neutralgeneral
Compass Therapeutics, Inc. (CMPX) files 8-K
SEC 8-K50 · neutralgeneral
Compass Therapeutics, Inc. (CMPX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Compass Therapeutics to Participate in Upcoming June Investor Events | CMPX Stock News
StockTitan56 · neutralgeneral
Compass Therapeutics (CMPX) Reports Q1 2026 Net Loss of $18.3M
Yahoo Top34 · bearishearnings
Compass Minerals Announces Participation in Deutsche Bank’s 17th Annual Basic Materials Conference in June 2026
Morningstar56 · neutralgeneral
Canaccord Maintains Buy Rating on Compass Therapeutics (CMPX)
Yahoo Finance61 · neutralanalyst